Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Scionti

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative PropertiesRoberta Rocca, Francesca Scionti, Matteo Nadai, et al.
ACS Omega|December 7, 2020
Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome ProfilingMario Russo, Luca Tirinato, Francesca Scionti, et al.
Clinical Pharmacology and Therapeutics|February 11, 2019
Polymorphic Variants in NR1I3 and UGT2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case-Control StudyMariamena Arbitrio, Francesca Scionti, Emanuela Altomare, et al.
Oncotarget|November 9, 2016
Genetic variants associated with gastrointestinal symptoms in Fabry diseaseMaria Teresa Di Martino, Francesca Scionti, Simona Sestito, et al.
International Journal of Molecular Sciences|November 25, 2020
Circulating Coding and Long Non-Coding RNAs as Potential Biomarkers of Idiopathic Pulmonary FibrosisStefania Di Mauro, Alessandra Scamporrino, Mary Fruciano, et al.
Haematologica|February 22, 2020
Exploiting MYC-induced PARPness to target genomic instability in multiple myelomaDaniele Caracciolo, Francesca Scionti, Giada Juli, et al.
International Journal of Molecular Sciences|September 23, 2022
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple MyelomaKatia Grillone, Caterina Riillo, Roberta Rocca, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 28, 2024
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experienceNicoletta Staropoli, Francesca Scionti, Valentina Farenza, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 26, 2023
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myelomaFrancesca Scionti, Giada Juli, Roberta Rocca, et al.
Leukemia|August 19, 2018
miR-22 suppresses DNA ligase III addiction in multiple myelomaDaniele Caracciolo, Maria Teresa Di Martino, Nicola Amodio, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative PropertiesRoberta Rocca, Francesca Scionti, Matteo Nadai, et al.
ACS Omega|December 7, 2020
Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome ProfilingMario Russo, Luca Tirinato, Francesca Scionti, et al.
Clinical Pharmacology and Therapeutics|February 11, 2019
Polymorphic Variants in NR1I3 and UGT2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case-Control StudyMariamena Arbitrio, Francesca Scionti, Emanuela Altomare, et al.
Oncotarget|November 9, 2016
Genetic variants associated with gastrointestinal symptoms in Fabry diseaseMaria Teresa Di Martino, Francesca Scionti, Simona Sestito, et al.
International Journal of Molecular Sciences|November 25, 2020
Circulating Coding and Long Non-Coding RNAs as Potential Biomarkers of Idiopathic Pulmonary FibrosisStefania Di Mauro, Alessandra Scamporrino, Mary Fruciano, et al.
Haematologica|February 22, 2020
Exploiting MYC-induced PARPness to target genomic instability in multiple myelomaDaniele Caracciolo, Francesca Scionti, Giada Juli, et al.
International Journal of Molecular Sciences|September 23, 2022
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple MyelomaKatia Grillone, Caterina Riillo, Roberta Rocca, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 28, 2024
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experienceNicoletta Staropoli, Francesca Scionti, Valentina Farenza, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 26, 2023
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myelomaFrancesca Scionti, Giada Juli, Roberta Rocca, et al.
Leukemia|August 19, 2018
miR-22 suppresses DNA ligase III addiction in multiple myelomaDaniele Caracciolo, Maria Teresa Di Martino, Nicola Amodio, et al.
Pageof 6